Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Sweden · Delayed Price · Currency is SEK 457.40
-1.00 (-0.22%)
Jul 24, 2026, 5:29 PM CET
STO:SOBI Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,238 | 34 | 4,407 | 2,954 | 3,321 | 3,295 |
Depreciation & Amortization | 10,307 | 10,096 | 3,679 | 3,200 | 2,419 | 2,006 |
Other Adjustments | 26 | 269 | -212 | 118 | 316 | 179 |
Change in Receivables | - | -884 | -178 | -900 | -1,982 | 452 |
Changes in Inventories | - | -1,077 | -159 | 286 | 413 | -318 |
Changes in Accounts Payable | - | 1,454 | 157 | -546 | 763 | 980 |
Changes in Income Taxes Payable | -1,424 | -1,327 | -307 | -641 | -673 | -1,124 |
Changes in Other Operating Activities | -2,289 | - | - | - | - | - |
Operating Cash Flow | 7,859 | 8,565 | 7,388 | 4,470 | 4,576 | 5,470 |
Operating Cash Flow Growth | 16.59% | 15.93% | 65.28% | -2.32% | -16.34% | 11.04% |
Capital Expenditures | -110 | -139 | -255 | -873 | -72 | -47 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 3 |
Purchases of Intangible Assets | -3,288 | -3,113 | -2,835 | -4,070 | -1,405 | -323 |
Purchases of Investments | -23 | -1,045 | - | - | - | - |
Cash Acquisitions | -8,474 | - | - | -16,961 | - | - |
Other Investing Activities | - | 2 | - | - | - | - |
Investing Cash Flow | -12,900 | -4,294 | -3,091 | -21,904 | -1,477 | -367 |
Long-Term Debt Issued | 4,581 | 3,055 | 14,220 | 35,876 | 13,675 | 14,193 |
Long-Term Debt Repaid | - | -7.99 | -18,656 | -24,628 | -16,094 | -18,191 |
Net Long-Term Debt Issued (Repaid) | 4,581 | 3,047 | -4,436 | 11,248 | -2,419 | -3,998 |
Issuance of Common Stock | 334 | 245 | 427 | 6,129 | 89 | - |
Net Common Stock Issued (Repurchased) | 334 | 245 | 427 | 6,129 | 89 | - |
Other Financing Activities | 125 | 365 | 8 | -364 | -571 | -476 |
Financing Cash Flow | 5,041 | -4,323 | -4,001 | 17,012 | -2,902 | -4,474 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 24 | -46 | -61 | -35 | 119 | 12 |
Net Cash Flow | 1 | -52 | 296 | -422 | 197 | 629 |
Free Cash Flow | 7,749 | 8,426 | 7,133 | 3,597 | 4,504 | 5,423 |
Free Cash Flow Growth | 18.13% | 18.13% | 98.30% | -20.14% | -16.95% | 11.01% |
FCF Margin | 25.30% | 29.84% | 27.41% | 16.26% | 23.97% | 34.92% |
Free Cash Flow Per Share | 22.20 | 24.24 | 20.64 | 11.03 | 14.41 | 18.27 |
Levered Free Cash Flow | 12,447 | 12,532 | 2,564 | 15,083 | 3,069 | 178 |
Unlevered Free Cash Flow | 8,713 | 21,145 | 8,066 | 4,740 | 5,879 | 4,532 |